Correction to: Acta Pharmacologica Sinica https://doi.org/10.1038/s41401-021-00853-8, published online 07 February 2022

Western blot images of p-AKT and AKT in Fig. 8c and 8d were inadvertently misplaced in the process of assembling figures. The correct versions are shown. The corrigendum does not affect the conclusion. The authors apologize for any inconvenience this may have caused. The original article has been corrected.

Corrected:

Fig. 8: LY294002 and U0126 had concurrent effects on p-ERK1/2 and p-AKT.
figure a

c, d BV-2 cells were pretreated for 5 min with U0126 (20 μM) and then stimulated for 30 min with either 2-AG (10 μM) or JWH015 (10 μM). Whole-cell lysates were prepared and immunoblotted as described in Materials and Methods with antibodies that recognize p-AKT (Ser473) and total AKT. The densitometric data represent the means ± SD of two independent experiments performed in triplicate. *P < 0.05, **P < 0.01 vs control group. ###P < 0.001 vs 2-AG or JWH015 treated-group.